Harmony Biosciences Holdings
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Check the tech stack behind harmonybiosciences.com. Find a founder email at harmonybiosciences.com.
About
Harmony Biosciences Holdings is a biopharmaceutical company dedicated to addressing unmet medical needs in rare neurological diseases. Their primary focus is on developing and commercializing therapies for conditions such as narcolepsy. They aim to improve the lives of patients by providing novel treatment options. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Harmony Biosciences Holdings do?
Harmony Biosciences Holdings is a Biotech company that offers Services. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Plymouth Meeting, United States and was founded in 2017. Public records show about 332 people and $401M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Harmony Biosciences Holdings raised?
Harmony Biosciences Holdings has raised a total of $401M in funding. The most recent round on record is IPO.
Where is Harmony Biosciences Holdings headquartered?
Harmony Biosciences Holdings is headquartered in Plymouth Meeting, United States.
When was Harmony Biosciences Holdings founded?
Harmony Biosciences Holdings was founded in 2017.
What industry does Harmony Biosciences Holdings operate in?
Harmony Biosciences Holdings operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Harmony Biosciences Holdings have?
Harmony Biosciences Holdings has approximately 332 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.